Data / Form D filings / OX2 Therapeutics, Inc.
OX2 Therapeutics, Inc.: Form D filings
OX2 Therapeutics, Inc., a biotechnology company in Minneapolis, MN, filed 2 Form D notices with the SEC between 2017 and 2020. The latest, on September 22, 2020, reports $649,415 sold of a $750,007 offering to 15 investors.
Find out what OX2 Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1621 E. Hennepin Avenue, Suite 290, Minneapolis, MN, 55414
- Phone
- (612) 309-7653
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2016
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1704490
The full lists. Form D filings in Minnesota: 692 rows, $34.60, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 22, 2020 | New notice | $750,007 | $649,415 | $100,592 | 15 | Aug 20, 2020 | sec.gov |
| May 17, 2017 | New notice | $3,060,997 | $305,002 | $2,755,995 | 4 | Mar 29, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Rob Parish | Director | |
| Ben Oehler | Director | |
| Christopher Moertel | Executive Officer, Director | |
| Jeff Liter | Executive Officer, Promoter | |
| Andrea Hunt | Director | |
| Mike Olin | Executive Officer, Director |
Other biotechnology companies in Minnesota that filed recently
- Medical 21, Inc. $550,000 · Oct 23, 2026
- InSitu Biologics, Inc. $1.3 million · Oct 14, 2026
- Evia Bio, Inc. $5.5 million · Sep 28, 2026
- EyeMacular Regeneration, Inc. $2.9 million · Sep 25, 2026
- ProEncia Biotechnology Inc. $1.5 million · Aug 26, 2026
Every Form D from the week of Sep 21, 2020 · All recent filings in Minnesota · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what OX2 Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.